Oral targeted therapies

被引：0
|
作者：
Etienne-Selloum, Nelly [1 ,2 ]
机构：
[1] Univ Strasbourg, Lab Bioimagerie & Pathol LBP Equipe Tumoral Signa, Fac Pharm, Unistra,CNRS,UMR 7021, 74 Route Rhin,CS 60024, F-67401 Illkirch Graffenstaden, France
[2] Ctr Lutte Canc Paul Strauss, Dept Pharm, 3 Rue Porte Hop, F-67000 Strasbourg, France
来源：
ACTUALITES PHARMACEUTIQUES | 2018年 / 57卷 / 578期
关键词：
angiogenesis; BCR/ABL; BRAF; EGFR; kinase inhibitor; MEK; targeted therapy;
D O I：
10.1016/j.actpha.2018.05.007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Lack of selectivity associated with a low therapeutic index of cytotoxic drugs together with improved knowledge of the carcinogenesis mechanisms have led to the development of a new therapeutic strategy for cancer which is more targeted and theoretically less toxic. Anticancer targeted therapies can kill cancer cells more selectively by interfering with specific protein or process involved in cancer growth. These treatments have considerably improved survival and quality of life of patients, most of them being self-administered at home. (C) 2018 Elsevier Masson SAS. All rights reserved
引用
收藏
页码：13 / 18
页数：6
相关论文
共 50 条
  • [1] Oral toxicity of targeted anticancer therapies
    Sibaud, V.
    Boralevi, F.
    Vigarios, E.
    Fricain, J. -C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2014, 141 (05): : 354 - 363
  • [2] Targeted cancer therapies Oral health care implications
    Georgakopoulou, Eleni
    Stebbing, Justin
    Scully, Crispian
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2018, 149 (02): : 100 - 111
  • [3] Targeted Oral Therapies in the Treatment of Pulmonary Arterial Hypertension
    Safdar, Zeenat
    CLINICAL DRUG INVESTIGATION, 2010, 30 (12) : 811 - 826
  • [4] Targeted Oral Therapies in the Treatment of Pulmonary Arterial Hypertension
    Zeenat Safdar
    Clinical Drug Investigation, 2010, 30 : 811 - 826
  • [5] Small molecule oral targeted therapies in ulcerative colitis
    Shivaji, Uday N.
    Nardone, Olga Maria
    Cannatelli, Rosanna
    Smith, Samuel Cl
    Ghosh, Subrata
    Iacucci, Marietta
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (09): : 850 - 861
  • [6] Oral complications of targeted cancer therapies: A narrative literature review
    Watters, A. L.
    Epstein, J. B.
    Agulnik, M.
    ORAL ONCOLOGY, 2011, 47 (06) : 441 - 448
  • [7] Developing new oral targeted therapies for RA can be challenging
    Fleischmann, Roy M.
    NATURE REVIEWS RHEUMATOLOGY, 2015, 11 (01) : 5 - 6
  • [8] Oral Targeted Therapies and Central Nervous System (CNS) Metastases
    Michael P. Gabay
    Scott M. Wirth
    Joan M. Stachnik
    Colleen L. Overley
    Katie E. Long
    Linda R. Bressler
    John L. Villano
    CNS Drugs, 2015, 29 : 935 - 952
  • [9] Plasma drug monitoring implementation of oral targeted therapies in oncology
    Meynial, O.
    Blanchet, B.
    Gohari, A.
    Fallet, V.
    Ruppert, A. -M.
    Canellas, A.
    Lavole, A.
    Rosencher, L.
    Epaud, C.
    Chaabane, N.
    Richard, S.
    Wislez, M.
    Debrix, I.
    Lotz, J. -P.
    Cadranel, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 365 - 366
  • [10] Developing new oral targeted therapies for RA can be challenging
    Roy M. Fleischmann
    Nature Reviews Rheumatology, 2015, 11 : 4 - 6
12345